England, Wales and Scotland Launch MenB Vaccine Drive for One Million Young People

UK Launches Mass Meningitis B Vaccination Programme for Young Adults

Approximately one million young people across England, Wales, and Scotland are set to be offered a meningitis B vaccine as part of a significant one-off public health initiative. The programme has been triggered by the UK's largest and fastest-spreading outbreak of meningitis B on record, which emerged in Kent earlier this year, along with two additional concerning clusters identified in Weymouth, Dorset, and Reading, Berkshire.

Who Is Eligible for the Vaccine?

The two-dose MenB vaccination programme is designed to reach those considered at the highest immediate risk. Eligibility broadly covers:

• Year 13 pupils in England and Wales, and S6 students in Scotland
• Those aged 18 to 25 who are entering university or residential further education for the first time this autumn
• International students under the age of 25 beginning their first year are encouraged to receive their initial dose before arriving in the UK where possible

Health officials have highlighted that young people transitioning into university environments face elevated risk due to increased social mixing, communal living arrangements, and behaviours such as sharing drinks or vapes — all of which can facilitate the spread of meningococcal bacteria.

A Devastating Loss That Underscores the Urgency

The human cost of meningitis B is painfully illustrated by the story of Aaron Mills, an 18-year-old from Kidderminster, Worcestershire, who passed away in January 2026. Aaron had recently begun studying at John Moores University in Liverpool and was home for the Christmas holidays when he developed what appeared to be mild flu-like symptoms.

On 30 December, he went to bed complaining of a headache. Just thirty minutes later, his family found him fitting and unresponsive. He died shortly after.

His father revealed that the family had assumed Aaron was protected, as he had previously received a meningitis vaccine. However, they later learned that different vaccines target different strains of the disease. The MenACWY vaccine, routinely offered to teenagers at age 14, covers separate strains and does not protect against meningitis B.

"The impact this has had on the family and friends is horrific. The pain is unbearable," his father said.

How and When Can Young People Get Vaccinated?

England

In England, the two doses will be available through community pharmacies during July and August. Importantly, recipients do not need to attend the same pharmacy for both injections. Year 13 students will be contacted directly via the NHS app, text message, email, or letter depending on their health records. Those aged 18 to 25 starting university for the first time can book appointments directly with participating pharmacies.

Wales

The Welsh vaccination programme will run from July through to December. Young people aged 17 to 18 can expect a letter from their local health board from early July, while those aged 18 to 25 entering higher education will be able to contact their health board later that month.

Scotland

Scotland's programme is also scheduled to begin in July, with further rollout details to follow.

Northern Ireland

Authorities have confirmed that Northern Ireland will launch a similar programme in due course.

Two doses are required for maximum protection, with a minimum interval of 28 days between each injection.

Government Response and Public Health Rationale

England's Secretary of State for Health and Social Care, James Murray, emphasised the seriousness of the current situation, stating that the Kent outbreak and subsequent clusters suggest a possible shift in how meningitis B is spreading through the population.

"While we assess the latest evidence, we are acting now to help protect young people at highest immediate risk as they enter university and residential colleges this autumn," Murray said. "By offering two doses of the jabs ahead of the academic year, we will help reduce the risk of serious illness and larger outbreaks of this horrendous disease."

Meningococcal disease can progress rapidly into life-threatening conditions, making early vaccination critical. Health officials are urging all eligible individuals to take up the offer as promptly as possible to ensure full protection before the autumn term begins.